BioNTech, Pfizer initiate rolling submission to EMA for SARS-CoV-2 vaccine candidate

BioNTech and Pfizer have initiated rolling submission to EMA for SARS-CoV-2 vaccine candidate. (Credit: Gerd Altmann from Pixabay)